This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Firpi RJ et al. (2005) Short recovery time after percutaneous liver biopsy: should we change our current practices? Clin Gastroenterol Hepatol 3: 926–929
Sohal AS et al. (2006) Uremic bleeding: pathophysiology and clinical risk factors. Thromb Res 118: 417–427
Sterling RK et al. (1999) Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 94: 3576–3582
Cotler SJ et al. (2002) Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol 35: 191–195
Acknowledgements
The synopsis was written by Lisa Richards, Editorial Assistant, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kallwitz, E., Cotler, S. Is percutaneous liver biopsy safe in patients with hepatitis C and end-stage renal disease?. Nat Rev Gastroenterol Hepatol 5, 420–421 (2008). https://doi.org/10.1038/ncpgasthep1183
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep1183